IMPLANT SITE URTICARIA

IMPLANT SITE URTICARIA was reported 98 times

IMPLANT SITE URTICARIA is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Progestin [EPC] 83 0.0003
1 Provitamin D2 Compound [EPC] 2 0.0001
2 Central alpha-2 Adrenergic Agonist [EPC] 1 0.0000
3 Anti-epileptic Agent [EPC] 4 0.0000
4 Thiazide Diuretic [EPC] 1 0.0000
5 Mood Stabilizer [EPC] 1 0.0000
6 Atypical Antipsychotic [EPC] 2 0.0000
7 Osmotic Laxative [EPC] 1 0.0000
8 Vitamin D [EPC] 1 0.0000
9 Vitamin B12 [EPC] 1 0.0000
10 Vitamin C [EPC] 1 0.0000
11 Proton Pump Inhibitor [EPC] 1 0.0000
12 Benzodiazepine [EPC] 1 0.0000
13 Nonsteroidal Anti-inflammatory Drug [EPC] 1 0.0000